ExPEC4V

ExPEC4V
Vaccine description
TargetEscherichia coli[1]
Vaccine typeconjugate[1]
Clinical data
Other namesExPEC4-V; ExPEC-4V; ExPECV4; ExPEC-V4; JNJ-63871860; JNJ63871860
Routes of
administration		Intramuscular injection[1]

ExPEC4V, also known as JNJ-63871860, is a vaccine against urinary tract infections (UTIs) and Escherichia coli infection.[2][1][3][4] It is an Escherichia coli polysaccharide conjugate vaccine.[2][1][4] The vaccine is administered by intramuscular injection.[1] It is being developed by GlycoVaxyn and Johnson & Johnson.[2] As of November 2023, ExPEC4V is in phase 2 clinical trials.[2] There is also a 10-valent form called ExPEC10V (VAC-52416; JNJ-69968054).[4][5] In February 2025 Johnson & Johnson stopped the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.[6]

See also

References

  1. ^ a b c d e f Huttner A, Gambillara V (October 2018). "The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli". Clinical Microbiology and Infection. 24 (10): 1046–1050. doi:10.1016/j.cmi.2018.05.009. PMID 29803843.
  2. ^ a b c d "JNJ 63871860". AdisInsight. 5 November 2023. Retrieved 26 February 2025.
  3. ^ Qiu L, Chirman D, Clark JR, Xing Y, Hernandez Santos H, Vaughan EE, et al. (2024). "Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges". Gut Microbes. 16 (1) 2359691. doi:10.1080/19490976.2024.2359691. PMC 11152113. PMID 38825856.
  4. ^ a b c Doiron RC, Cotechini T, Nickel JC (June 2024). "It's Time to Embrace Vaccination as We Enter the Postantibiotic Era of Recurrent Urinary Tract Infection Management". The Journal of Urology. 211 (6): 797–799. doi:10.1097/JU.0000000000003969. PMID 38704743.
  5. ^ "VAC 52416". AdisInsight. 28 April 2023. Retrieved 26 February 2025.
  6. ^ "J&J stops Phase III trial of Sanofi's E. Coli vaccine citing 'disappointing' results". Clinical Trials Arena. February 13, 2025.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.